当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析

复星医药

(600196)

  

流通市值:525.39亿  总市值:662.75亿
流通股本:21.18亿   总股本:26.72亿

复星医药(600196)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润26.54亿元,每股收益0.86元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益5598235.98万元,未分配利润2441165.57万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产11076724.43万元,负债5478488.45万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入30,700,119,056.1221,395,192,579.8810,870,720,838.6643,951,546,895.23
营业总成本30,284,279,170.4720,632,041,911.7310,098,284,416.3341,346,264,436.82
营业利润3,342,197,770.862,682,610,757.241,427,139,292.414,656,656,381.28
利润总额3,292,456,489.612,655,469,971.171,384,764,032.274,574,381,584.81
净利润2,653,809,536.672,045,225,278.441,114,254,110.163,947,464,120.11
其他综合收益383,047,217.57475,605,847.37-183,486,478.67108,043,490.32
综合收益总额3,036,856,754.242,520,831,125.81930,767,631.494,055,507,610.43
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计34,914,164,504.4436,851,027,973.835,179,941,530.9935,279,178,142.82
非流动资产合计75,853,079,792.3775,291,661,172.0672,199,433,860.871,884,729,089.52
资产总计110,767,244,296.81112,142,689,145.86107,379,375,391.79107,163,907,232.34
流动负债合计34,506,297,652.4436,818,803,620.3432,468,080,488.9233,298,069,457.25
非流动负债合计20,278,586,889.7219,874,971,591.1819,863,580,280.0119,756,928,161.74
负债合计54,784,884,542.1656,693,775,211.5252,331,660,768.9353,054,997,618.99
归属于母公司股东权益合计45,919,376,269.1345,460,014,201.145,393,160,518.3544,582,457,512.55
股东权益合计55,982,359,754.6555,448,913,934.3455,047,714,622.8654,108,909,613.35
负债和股东权益合计110,767,244,296.81112,142,689,145.86107,379,375,391.79107,163,907,232.34
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计33,435,825,453.0722,884,708,865.7711,865,511,092.1746,128,040,114.67
经营活动现金流出小计30,974,184,966.4321,074,700,731.1510,992,267,055.8141,910,469,221.8
经营活动产生的现金流量净额2,461,640,486.641,810,008,134.62873,244,036.364,217,570,892.87
投资活动现金流入小计3,127,265,876.222,437,627,459.061,722,702,099.116,474,890,264.46
投资活动现金流出小计6,411,558,906.844,799,653,870.211,859,877,488.1510,538,928,425.12
投资活动产生的现金流量净额-3,284,293,030.62-2,362,026,411.15-137,175,389.04-4,064,038,160.66
筹资活动现金流入小计18,436,543,786.1713,971,277,678.257,060,114,364.3235,286,556,975.9
筹资活动现金流出小计18,833,123,390.6512,571,368,305.616,778,143,209.8730,858,082,242.4
筹资活动产生的现金流量净额-396,579,604.481,399,909,372.64281,971,154.454,428,474,733.5
汇率变动对现金及现金等价物的影响131,327,968.7741,414,806.15-67,365,428.91128,342,457.74
现金及现金等价物净增加额-1,087,904,179.69889,305,902.26950,674,372.864,710,349,923.45
期末现金及现金等价物余额10,082,162,808.8612,059,372,890.8112,120,741,361.4111,170,066,988.55
TOP↑